Data as of Apr 17
| -0.15 / -5.62%|
The 3 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 6.00, with a high estimate of 6.50 and a low estimate of 5.00. The median estimate represents a +138.10% increase from the last price of 2.52.
The current consensus among 4 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.